Related Experiment Video
Updated: Jun 25, 2025

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
Published on: August 28, 2021
Combining melatonin with dexmedetomidine improves anesthesia in rats
Joaquín Cogo Pagella1, María F Rodríguez1, Fabricio Frisina1
1Institute of Basic and Experimental Sciences (IBES, SeCyT-UM), University of Morón, Argentina.
Combining melatonin (ML) and dexmedetomidine (DM) provides effective anesthesia in rats. This combination reduces the required dexmedetomidine dose, mitigating its side effects.
Area of Science:
- Veterinary Anesthesiology
- Pharmacology
- Animal Models
Background:
- Melatonin (ML) and dexmedetomidine (DM) are independently used for anesthesia and premedication in humans and animals.
- Investigating synergistic or additive anesthetic effects of drug combinations is crucial for optimizing anesthetic protocols.
Purpose of the Study:
- To evaluate the combined anesthetic properties of melatonin and dexmedetomidine in rats.
- To determine optimal dosage ratios for achieving surgical anesthesia with reduced side effects.
Main Methods:
- Rats were administered various combinations of melatonin (50, 100 mg/kg) and dexmedetomidine (50, 100 μg/kg).
- Anesthetic effects were assessed by observing behavioral changes and measuring the duration and depth of anesthesia.
- Anesthetic intervals were defined by the loss and recovery of specific reflexes.
Main Results:
- Individual doses of melatonin or dexmedetomidine did not produce adequate anesthetic effects.
- Combinations of ML50+DM100, ML100+DM50, and ML100+DM100 yielded surgical anesthesia durations ranging from 60 to 360 minutes.
- The co-administration of melatonin allowed for a reduction in the dexmedetomidine dosage.
Conclusions:
- The combination of melatonin and dexmedetomidine demonstrates significant anesthetic potential in rats.
- Melatonin can be used to decrease the dose of dexmedetomidine, thereby reducing the incidence of adverse effects associated with this alpha-2 agonist.
More Related Videos
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Stages of General Anesthesia

